Evidence map›Paper›PMID 23462688›Full record

ArticleToxins2013

P2X receptor-dependent erythrocyte damage by α-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells.

Steen K Fagerberg, Marianne Skals, Jens Leipziger, Helle A Praetorius

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Erythrocyte P2XCritical care (London, England) · 2018
    Article
  4. Article
  5. Article
  6. P2XFrontiers in cellular and infection microbiology · 2017
    Article
  7. Article
  8. Review
  9. P2X and P2Y receptor signaling in red blood cells.Frontiers in molecular biosciences · 2015
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Steen K FagerbergDepartment of Biomedicine, Physiology, Aarhus University, Aarhus C, Denmark. steenfagerberg@gmail.com
Marianne Skals
Jens Leipziger
Helle A Praetorius
Aarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pore-forming exotoxin α-hemolysin from E. coli causes a significant volume reduction of human erythrocytes that precedes the ultimate swelling and lysis. This shrinkage results from activation of Ca2+-sensitive K+ (KCa3.1) and Cl- channels (TMEM16A) and reduced functions of either of these channels potentiate the HlyA-induced hemolysis. This means that Ca2+-dependent activation of KCa3.1 and TMEM16A protects the cells against early hemolysis. Simultaneous to the HlyA-induced shrinkage, the erythrocytes show increased exposure of phosphatidylserine (PS) in the outer plasma membrane leaflet, which is known to be a keen trigger for phagocytosis. We hypothesize that exposure to HlyA elicits removal of the damaged erythrocytes by phagocytic cells. Cultured THP-1 cells as a model for erythrocytal phagocytosis was verified by a variety of methods, including live cell imaging. We consistently found the HlyA to very potently trigger phagocytosis of erythrocytes by THP-1 cells. The HlyA-induced phagocytosis was prevented by inhibition of KCa3.1, which is known to reduce PS-exposure in human erythrocytes subjected to both ionomycin and HlyA. Moreover, we show that P2X receptor inhibition, which prevents the cell damages caused by HlyA, also reduced that HlyA-induced PS-exposure and phagocytosis. Based on these results, we propose that erythrocytes, damaged by HlyA-insertion, are effectively cleared from the blood stream. This mechanism will potentially reduce the risk of intravascular hemolysis.

Indexed as

Bacterial ToxinsCell Culture TechniquesCell LineCell ShapeCell SizeCytophagocytosisErythrocytesEscherichia coli ProteinsFlow CytometryFluorescent DyesHemolysin ProteinsHemolysisHumansIntermediate-Conductance Calcium-Activated Potassium ChannelsMacrophagesPotassium Channel BlockersBacterial ToxinsEscherichia coli ProteinsFluorescent DyesHemolysin ProteinsHlya protein, E coliIntermediate-Conductance Calcium-Activated Potassium ChannelsKCNN4 protein, humanPotassium Channel BlockersPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X

Identifiers

PMID23462688
PMCPMC3705273
OpenAlexW2054435184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.